Concepedia

Christopher Ruel

CR

Statistics

Publications

31

Citations

1.6K

H-Index

23

Active since

2004

Affiliations

City of Hope(Current)

City Of Hope National Medical Center

University of California, Davis

University of Southern California

National Cancer Institute

Christopher Ruel is an author at City of Hope specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2004–2023

31

Publications

31

Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel et al. · Journal of Thoracic Oncology · 2009 · 157 citations · Full text

, , +8

Trastuzumab plus docetaxel in HER‐2/<i>neu</i>‐positive prostate carcinoma

Primo N. Lara, Karen Giselle Chee, Jeff Longmate et al. · Cancer · 2004 · 114 citations

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients

Colt A. Egelston, Christian Avalos, Travis Y. Tu et al. · JCI Insight · 2019 · 109 citations · Full text

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i> - or <i>BRCA2</i> -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

George Somlo, Paul Frankel, Banu Arun et al. · Clinical Cancer Research · 2017 · 96 citations · Full text

Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel et al. · Urology · 2010 · 86 citations · Full text

, , +6

1–5 of 31